Inside Nephrology: A Weekly Review
Nefrologia
Kidney Health Frontiers: From CKM Syndrome to Transplant Monitoring
This week's nephrology update covers groundbreaking research on CKM syndrome, global CKD burden, metabolic determinants of autoimmune kidney disease, sex differences in PD outcomes, decentralized CKD trials, transplant monitoring advances, and improved CV risk assessment tools.
Accedi o Registrati per ascoltare questo episodio
Bibliografia
1. ASN Kidney Health Guidance on the Cardiovascular-Kidney-Metabolic Syndrome.
Authors: Bansal N, Bjornstad P, Bress AP, et al.
Journal: Journal of the American Society of Nephrology : JASN, 2026 Oct 1
PMID: 42684397
DOI: 10.1681/ASN.0000001231
2. The updated global burden of chronic kidney disease: one death every 20 seconds.
Authors: Ortiz A, Lees JS, Torra R, et al.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2026 Sep 30
PMID: 41739048
DOI: 10.1093/ndt/gfag040
3. The SLC-ome of membrane transport: from molecular discovery to physiology and clinical applications.
Authors: Gyimesi G, Tweedie S, Bruford E, et al.
Journal: Physiological reviews, 2026 Oct 1
PMID: 41026912
DOI: 10.1152/physrev.00001.2024
4. Sex-Specific Outcomes in the Peritoneal Dialysis Outcomes and Practice Patterns Study.
Authors: Albakr R, Sylvertooth D, Bieber B, et al.
Journal: Clinical journal of the American Society of Nephrology : CJASN, 2026 Oct 1
PMID: 41370095
DOI: 10.2215/CJN.0000000937
5. Feasibility of Decentralised Response-Guided Albuminuria Monitoring to Optimise Empagliflozin and Finerenone Therapy in Type 2 Diabetes and Chronic Kidney Disease.
Authors: Beernink JM, Laverman GD, Heerspink HJL
Journal: Diabetes, obesity & metabolism, 2026 Oct
PMID: 42530392
DOI: 10.1111/dom.71147
6. Clinical Relevance of Donor-Derived Cell-Free DNA in Monitoring Kidney Transplant Rejection.
Authors: Pagliazzi A, Wellekens K, de Loor H, et al.
Journal: Journal of the American Society of Nephrology : JASN, 2026 Oct 1
PMID: 42133430
DOI: 10.1681/ASN.0000001116
7. Metabolic determinants of autoimmune kidney diseases.
Authors: Scindia Y, Morel L
Journal: Nature reviews. Nephrology, 2026 Oct
PMID: 42410158
DOI: 10.1038/s41581-026-01096-8
8. Cardiovascular Risk Assessment Tools in CKD.
Authors: Zoccali C, Stel VS, Mallamaci F, et al.
Journal: Clinical journal of the American Society of Nephrology : CJASN, 2026 Oct 1
PMID: 41661676
DOI: 10.2215/CJN.0000001025
9. A Cerebral Ethiodized Embolism after Lymphangiography: A Case Report and Literature Review.
Authors: Sawada J, Iwamoto H, Ishitoya S, et al.
Journal: Internal medicine (Tokyo, Japan), 2026 Oct 1
PMID: 41730621
DOI: 10.2169/internalmedicine.6727-25
10. Long-term mortality and risk of chronic kidney disease in children following severe malaria complicated by acute kidney injury: a prospective observational study.
Authors: Mellencamp KA, Namazzi R, Batte A, et al.
Journal: The Lancet. Global health, 2026 Oct
PMID: 42575118
DOI: 10.1016/j.langlo.2026.103984
Authors: Bansal N, Bjornstad P, Bress AP, et al.
Journal: Journal of the American Society of Nephrology : JASN, 2026 Oct 1
PMID: 42684397
DOI: 10.1681/ASN.0000001231
2. The updated global burden of chronic kidney disease: one death every 20 seconds.
Authors: Ortiz A, Lees JS, Torra R, et al.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2026 Sep 30
PMID: 41739048
DOI: 10.1093/ndt/gfag040
3. The SLC-ome of membrane transport: from molecular discovery to physiology and clinical applications.
Authors: Gyimesi G, Tweedie S, Bruford E, et al.
Journal: Physiological reviews, 2026 Oct 1
PMID: 41026912
DOI: 10.1152/physrev.00001.2024
4. Sex-Specific Outcomes in the Peritoneal Dialysis Outcomes and Practice Patterns Study.
Authors: Albakr R, Sylvertooth D, Bieber B, et al.
Journal: Clinical journal of the American Society of Nephrology : CJASN, 2026 Oct 1
PMID: 41370095
DOI: 10.2215/CJN.0000000937
5. Feasibility of Decentralised Response-Guided Albuminuria Monitoring to Optimise Empagliflozin and Finerenone Therapy in Type 2 Diabetes and Chronic Kidney Disease.
Authors: Beernink JM, Laverman GD, Heerspink HJL
Journal: Diabetes, obesity & metabolism, 2026 Oct
PMID: 42530392
DOI: 10.1111/dom.71147
6. Clinical Relevance of Donor-Derived Cell-Free DNA in Monitoring Kidney Transplant Rejection.
Authors: Pagliazzi A, Wellekens K, de Loor H, et al.
Journal: Journal of the American Society of Nephrology : JASN, 2026 Oct 1
PMID: 42133430
DOI: 10.1681/ASN.0000001116
7. Metabolic determinants of autoimmune kidney diseases.
Authors: Scindia Y, Morel L
Journal: Nature reviews. Nephrology, 2026 Oct
PMID: 42410158
DOI: 10.1038/s41581-026-01096-8
8. Cardiovascular Risk Assessment Tools in CKD.
Authors: Zoccali C, Stel VS, Mallamaci F, et al.
Journal: Clinical journal of the American Society of Nephrology : CJASN, 2026 Oct 1
PMID: 41661676
DOI: 10.2215/CJN.0000001025
9. A Cerebral Ethiodized Embolism after Lymphangiography: A Case Report and Literature Review.
Authors: Sawada J, Iwamoto H, Ishitoya S, et al.
Journal: Internal medicine (Tokyo, Japan), 2026 Oct 1
PMID: 41730621
DOI: 10.2169/internalmedicine.6727-25
10. Long-term mortality and risk of chronic kidney disease in children following severe malaria complicated by acute kidney injury: a prospective observational study.
Authors: Mellencamp KA, Namazzi R, Batte A, et al.
Journal: The Lancet. Global health, 2026 Oct
PMID: 42575118
DOI: 10.1016/j.langlo.2026.103984
